Azaindole Hydroxamic Acids are Potent HIV-1 Integrase Inhibitors
摘要:
HIV-1 integrase (IN) is one of three enzymes encoded by the HIV genome and is essential for viral replication. Recently, HIV-1 IN inhibitors have emerged as a new promising class of therapeutics. Herein, we report the discovery of azaindole carboxylic acids and azaindole hydroxamic acids as potent inhibitors of the HIV-1 IN enzyme and their structure-activity relationships. Several 4-fluorobenzyl substituted azaindole hydroxamic acids showed potent antiviral activities in cell-based assays and offered a structurally simple scaffold for the development of novel HIV-1 IN inhibitors.
Azaindole Hydroxamic Acids are Potent HIV-1 Integrase Inhibitors
摘要:
HIV-1 integrase (IN) is one of three enzymes encoded by the HIV genome and is essential for viral replication. Recently, HIV-1 IN inhibitors have emerged as a new promising class of therapeutics. Herein, we report the discovery of azaindole carboxylic acids and azaindole hydroxamic acids as potent inhibitors of the HIV-1 IN enzyme and their structure-activity relationships. Several 4-fluorobenzyl substituted azaindole hydroxamic acids showed potent antiviral activities in cell-based assays and offered a structurally simple scaffold for the development of novel HIV-1 IN inhibitors.
Azaindole Hydroxamic Acids are Potent HIV-1 Integrase Inhibitors
作者:Michael B. Plewe、Scott L. Butler、Klaus R. Dress、Qiyue Hu、Ted W. Johnson、Jon E. Kuehler、Atsuo Kuki、Hieu Lam、Wen Liu、Dawn Nowlin、Qinghai Peng、Sadayappan V. Rahavendran、Steven P. Tanis、Khanh T. Tran、Hai Wang、Anle Yang、Junhu Zhang
DOI:10.1021/jm900862n
日期:2009.11.26
HIV-1 integrase (IN) is one of three enzymes encoded by the HIV genome and is essential for viral replication. Recently, HIV-1 IN inhibitors have emerged as a new promising class of therapeutics. Herein, we report the discovery of azaindole carboxylic acids and azaindole hydroxamic acids as potent inhibitors of the HIV-1 IN enzyme and their structure-activity relationships. Several 4-fluorobenzyl substituted azaindole hydroxamic acids showed potent antiviral activities in cell-based assays and offered a structurally simple scaffold for the development of novel HIV-1 IN inhibitors.